Analyze Diet
Veterinary journal (London, England : 1997)2008; 180(3); 279-289; doi: 10.1016/j.tvjl.2008.08.004

Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.

Abstract: Equine herpes myeloencephalopathy (EHM), although a relatively uncommon manifestation of equine herpesvirus-1 (EHV-1) infection, can cause devastating losses on individual farms or boarding stables. Although outbreaks of EHM have been recognized for centuries in domestic horse populations, many aspects of this disease remained poorly characterized. In recent years, an improved understanding of EHM has emerged from experimental studies and from data collected during field outbreaks at riding schools, racetracks and veterinary hospitals throughout North America and Europe. These outbreaks have highlighted the contagious nature of EHV-1 and have prompted a re-evaluation of diagnostic procedures, treatment modalities, preventative measures and biosecurity protocols for the disease. This review concentrates on these and other selected, clinically relevant aspects of EHM.
Publication Date: 2008-09-19 PubMed ID: 18805030DOI: 10.1016/j.tvjl.2008.08.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper reviews recent studies and data collections on Equine herpes myeloencephalopathy (EHM), a harmful manifestation of the equine herpesvirus-1 (EHV-1) infection. The review focuses on the infectious nature of EHV-1 and its potential implications for diagnostic procedures, treatment approaches, prevention measures, and biosecurity protocols.

Equine Herpesvirus-1 Myeloencephalopathy (EHM)

  • The research paper revolves around EHM, a harmful manifestation of EHV-1 infection in horses. Although it’s relatively uncommon, it can cause devastating losses on individual farms or boarding stables and also impact riding schools, racetracks, and veterinary hospitals throughout North America and Europe.

Importance of Recent Developments

  • The latest experimental studies and field outbreak data have improved our understanding of EHM. The data collected during these outbreaks have highlighted the highly infectious nature of the EHV-1 virus.
  • These developments and the rising number of outbreaks have prompted a re-evaluation of various aspects related to EHM such as diagnostic procedures, treatment modalities, preventative measures and biosecurity protocols.

Clinically Relevant Aspects

  • Considering the potential impact of EHM on the equine population and the industries associated with it, understanding the clinically relevant aspects of EHM becomes crucial. This includes gaining insights into the transmission mechanisms of the EHV-1 virus, symptoms of the disease, innovative diagnostic tools, effective treatment methods, and disease prevention strategies.
  • The research paper endeavors to provide an overview of these clinically relevant aspects. The insights offered by the research help in promoting better health for the equine population and minimizing the economic repercussions of EHM outbreaks.

Cite This Article

APA
Pusterla N, David Wilson W, Madigan JE, Ferraro GL. (2008). Equine herpesvirus-1 myeloencephalopathy: a review of recent developments. Vet J, 180(3), 279-289. https://doi.org/10.1016/j.tvjl.2008.08.004

Publication

ISSN: 1090-0233
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 180
Issue: 3
Pages: 279-289

Researcher Affiliations

Pusterla, Nicola
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, One Shields Avenue, Davis, CA 95616, USA. npusterla@ucdavis.edu
David Wilson, W
    Madigan, John E
      Ferraro, Gregory L

        MeSH Terms

        • Animals
        • Disease Outbreaks / veterinary
        • Herpesviridae Infections / epidemiology
        • Herpesviridae Infections / veterinary
        • Herpesviridae Infections / virology
        • Herpesvirus 1, Equid / pathogenicity
        • Horse Diseases / epidemiology
        • Horse Diseases / virology
        • Horses
        • Nervous System Diseases / epidemiology
        • Nervous System Diseases / veterinary
        • Nervous System Diseases / virology

        References

        This article includes 80 references

        Citations

        This article has been cited 24 times.
        1. Carvalho KS, de Barros CSL, Mendonça FS, Machado M, Riet-Correa F. Diseases of the nervous system of equids in Brazil: a review. J Vet Diagn Invest 2025 Sep;37(5):729-752.
          doi: 10.1177/10406387251325881pubmed: 40443203google scholar: lookup
        2. Tsujimura K, Bannai H, Kambayashi Y, Nemoto M, Ohta M. Detection of equid alphaherpesvirus 1 in serum samples collected from infected horses. J Vet Diagn Invest 2025 May;37(3):495-498.
          doi: 10.1177/10406387251323272pubmed: 40022421google scholar: lookup
        3. de la Cuesta-Torrado M, Velloso Alvarez A, Cárdenas-Rebollo JM, Neira-Egea P, Vitale V, Cuervo-Arango J. Comparison of clinical variables and outcome of 2 natural equine herpesvirus myeloencephalopathy outbreaks induced by equine herpesvirus-1 A2254/N752 strain in sport horses. J Vet Intern Med 2025 Jan-Feb;39(1):e17287.
          doi: 10.1111/jvim.17287pubmed: 39778904google scholar: lookup
        4. Holmes CM, Wagner B. Characterization of Nasal Mucosal T Cells in Horses and Their Response to Equine Herpesvirus Type 1. Viruses 2024 Sep 25;16(10).
          doi: 10.3390/v16101514pubmed: 39459849google scholar: lookup
        5. Holmes CM, Babasyan S, Eady N, Schnabel CL, Wagner B. Immune horses rapidly increase antileukoproteinase and lack type I interferon secretion during mucosal innate immune responses against equine herpesvirus type 1. Microbiol Spectr 2024 Oct 3;12(10):e0109224.
          doi: 10.1128/spectrum.01092-24pubmed: 39162558google scholar: lookup
        6. Schramm A, Ackermann M, Eichwald C, Aguilar C, Fraefel C, Lechmann J. Antibody reactions of horses against various domains of the EHV-1 receptor-binding protein gD1. PLoS One 2024;19(7):e0301987.
          doi: 10.1371/journal.pone.0301987pubmed: 38995916google scholar: lookup
        7. Goehring L, Dorman DC, Osterrieder K, Burgess BA, Dougherty K, Gross P, Neinast C, Pusterla N, Soboll-Hussey G, Lunn DP. Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review. J Vet Intern Med 2024 May-Jun;38(3):1892-1905.
          doi: 10.1111/jvim.17016pubmed: 38380685google scholar: lookup
        8. Anderson C, Baha H, Boghdeh N, Barrera M, Alem F, Narayanan A. Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease. Viruses 2023 May 13;15(5).
          doi: 10.3390/v15051163pubmed: 37243249google scholar: lookup
        9. Phelps S, Chong D, McKenzie E, Kiupel M, Gorman E. Rapport de cas Mononuclear pleocytosis and meningoencephalitis caused by Listeria monocytogenes in an adult horse. Can Vet J 2023 Apr;64(4):363-366.
          pubmed: 37008639
        10. Attili AR, Colognato R, Preziuso S, Moriconi M, Valentini S, Petrini S, De Mia GM, Cuteri V. Evaluation of Three Different Vaccination Protocols against EHV1/EHV4 Infection in Mares: Double Blind, Randomized Clinical Trial. Vaccines (Basel) 2020 Jun 1;8(2).
          doi: 10.3390/vaccines8020268pubmed: 32492841google scholar: lookup
        11. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry. Front Microbiol 2019;10:2668.
          doi: 10.3389/fmicb.2019.02668pubmed: 31849857google scholar: lookup
        12. Lechmann J, Schoster A, Ernstberger M, Fouché N, Fraefel C, Bachofen C. A novel PCR protocol for detection and differentiation of neuropathogenic and non-neuropathogenic equid alphaherpesvirus 1. J Vet Diagn Invest 2019 Sep;31(5):696-703.
          doi: 10.1177/1040638719871975pubmed: 31477001google scholar: lookup
        13. Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease. J Virol 2019 Nov 15;93(22).
          doi: 10.1128/JVI.01011-19pubmed: 31462575google scholar: lookup
        14. Brown LJ, Brown G, Kydd J, Stout TAE, Schulman ML. Failure to detect equid herpesvirus types 1 and 4 DNA in placentae and healthy new-born Thoroughbred foals. J S Afr Vet Assoc 2019 May 30;90(0):e1-e5.
          doi: 10.4102/jsava.v90i0.1736pubmed: 31170779google scholar: lookup
        15. Poelaert KCK, Van Cleemput J, Laval K, Favoreel HW, Soboll Hussey G, Maes RK, Nauwynck HJ. Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense. Front Cell Infect Microbiol 2018;8:312.
          doi: 10.3389/fcimb.2018.00312pubmed: 30258819google scholar: lookup
        16. Schnabel CL, Wimer CL, Perkins G, Babasyan S, Freer H, Watts C, Rollins A, Osterrieder N, Wagner B. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity. BMC Vet Res 2018 Aug 22;14(1):245.
          doi: 10.1186/s12917-018-1563-4pubmed: 30134896google scholar: lookup
        17. Tallmadge RL, Žygelytė E, Van de Walle GR, Kristie TM, Felippe MJB. Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro. Front Vet Sci 2018;5:34.
          doi: 10.3389/fvets.2018.00034pubmed: 29594155google scholar: lookup
        18. Stasiak K, Dunowska M, Hills SF, Rola J. Genetic characterization of equid herpesvirus type 1 from cases of abortion in Poland. Arch Virol 2017 Aug;162(8):2329-2335.
          doi: 10.1007/s00705-017-3376-3pubmed: 28451902google scholar: lookup
        19. Zhao J, Poelaert KCK, Van Cleemput J, Nauwynck HJ. CCL2 and CCL5 driven attraction of CD172a(+) monocytic cells during an equine herpesvirus type 1 (EHV-1) infection in equine nasal mucosa and the impact of two migration inhibitors, rosiglitazone (RSG) and quinacrine (QC). Vet Res 2017 Feb 27;48(1):14.
          doi: 10.1186/s13567-017-0419-4pubmed: 28241864google scholar: lookup
        20. Spiesschaert B, Osterrieder N, Azab W. Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission. Viruses 2015 Feb 3;7(2):522-42.
          doi: 10.3390/v7020522pubmed: 25654240google scholar: lookup
        21. Marenzoni ML, Bietta A, Lepri E, Casagrande Proietti P, Cordioli P, Canelli E, Stefanetti V, Coletti M, Timoney PJ, Passamonti F. Role of equine herpesviruses as co-infecting agents in cases of abortion, placental disease and neonatal foal mortality. Vet Res Commun 2013 Dec;37(4):311-7.
          doi: 10.1007/s11259-013-9578-6pubmed: 24052369google scholar: lookup
        22. Walter J, Seeh C, Fey K, Bleul U, Osterrieder N. Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis. Acta Vet Scand 2013 Mar 5;55(1):19.
          doi: 10.1186/1751-0147-55-19pubmed: 23497661google scholar: lookup
        23. Glorieux S, Favoreel HW, Steukers L, Vandekerckhove AP, Nauwynck HJ. A trypsin-like serine protease is involved in pseudorabies virus invasion through the basement membrane barrier of porcine nasal respiratory mucosa. Vet Res 2011 Apr 14;42(1):58.
          doi: 10.1186/1297-9716-42-58pubmed: 21492440google scholar: lookup
        24. Heerkens TM. Equine herpesvirus-1, non-neurogenic pathotype, in a 9-year-old American Saddlebred with neurological signs. Can Vet J 2009 Mar;50(3):297-300.
          pubmed: 19436483